癌:信号通路和有针对性的治疗方法的进展
Aimin Jiang1, Jinxin Li1, Ziwei He1
1Department of Urology Changhai Hospital Naval Medical University Shanghai China.
MedComm
|August 2, 2024
概括
癌涉及复杂的信号通路,例如VHL/HIF和PI3K/AKT/mTOR. 了解这些分子机制是开发更好的向疗法和改善这种异质恶性瘤患者治疗结果的关键.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 癌是一种异质性恶性瘤,全球发病率和死亡率正在上升.
- 异常的信号通路,包括VHL/HIF,PI3K/AKT/mTOR和HGF/c-Met,驱动癌的开始和进展.
- 目前针对晚期癌的治疗方法,如向药物和免疫疗法,都有局限性.
研究的目的:
- 提供癌分子机制的全面概述.
- 强调信号通路的交叉和协同相互作用.
- 讨论针对性疗法和免疫疗法的进展.
主要方法:
- 对背后存在异常信号通路的分子机制的审查.
- 讨论针对性疗法 (铁氨酸激酶抑制剂) 和免疫疗法 (检查点抑制剂) 的最新进展.
- 强调多态学方法和网络分析,以了解监管网络.
主要成果:
- 在癌中对关键信号通路 (VHL/HIF,PI3K/AKT/mTOR,YAP,Wnt/ß-catenin,cAMP,HGF/c-Met) 的详细检查.
- 突出这些途径之间的复杂交叉和协同相互作用.
- 总结针对性药物和免疫疗法的当前局限性.
结论:
- 了解异常信号通路对于癌的发病过程至关重要.
- 多种经济学和网络分析对于阐明复杂的监管网络至关重要.
- 整合研究和临床见解可以改善诊断,精准医学和患者的治疗结果.
更多相关视频
12:22The Use of Reverse Phase Protein Arrays RPPA to Explore Protein Expression Variation within Individual Renal Cell Cancers
Published on: January 22, 2013
33.6K
07:42Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays
Published on: September 19, 2018
7.9K
相关概念视频
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
Non-Canonical Wnt Signaling Pathways
7.3K
Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.3K
Transducer Mechanism: Enzyme-Linked Receptors
2.4K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.4K
Canonical Wnt Signaling Pathway
8.7K
The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
8.7K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
